EYPT
Eyepoint Pharmaceuticals Inc
NASDAQ: EYPT · HEALTHCARE · BIOTECHNOLOGY
$13.20
+2.64% today
Updated 2026-04-30
Market cap
$1.08B
P/E ratio
—
P/S ratio
34.35x
EPS (TTM)
$-3.17
Dividend yield
—
52W range
$5 – $19
Volume
1.2M
Eyepoint Pharmaceuticals Inc (EYPT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-20.5%
Last 4 quarters
Revenue YoY growth
-94.6%
Most recent quarter
EPS YoY growth
-26.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.8%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-12.5%
2026-03-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-0.81 | -8.3% | $18.00 | $15.75 | -12.5% |
| 2025-11-05 | $-0.85 | -10.4% | $12.39 | $11.08 | -10.6% |
| 2025-08-07 | $-0.85 | -4.9% | $10.58 | $10.23 | -3.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.75 | $-0.81 | -8.3% | $620000.00 | -94.6% |
| 2025-09-30 | $-0.77 | $-0.85 | -10.4% | $966000.00 | -90.8% |
| 2025-06-30 | $-0.81 | $-0.85 | -4.9% | $5.33M | -43.7% |
| 2025-03-31 | $-0.41 | $-0.65 | -58.5% | $24.45M | +109.3% |
| 2024-12-31 | $-0.48 | $-0.64 | -34.3% | $11.59M | -17.4% |
| 2024-09-30 | $-0.55 | $-0.54 | +1.8% | $10.52M | -30.8% |
| 2024-06-30 | $-0.52 | $-0.58 | -11.5% | $9.48M | +4.1% |
| 2024-03-31 | $-0.42 | $-0.55 | -31.0% | $11.68M | +52.1% |
| 2023-12-31 | $-0.49 | $-0.33 | +32.7% | $14.03M | — |
| 2023-09-30 | $-0.51 | $-0.33 | +35.3% | $15.20M | — |
| 2023-06-30 | $0.60 | $-0.61 | -201.7% | $9.11M | — |
| 2023-03-31 | $-0.68 | $-0.56 | +17.6% | $7.68M | — |
Frequently asked questions
Has Eyepoint Pharmaceuticals Inc beaten earnings estimates?
Eyepoint Pharmaceuticals Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -20.5% over the last 4 quarters.
How does EYPT stock react to earnings?
EYPT stock has moved an average of -8.8% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is Eyepoint Pharmaceuticals Inc's revenue growth rate?
Eyepoint Pharmaceuticals Inc reported year-over-year revenue growth of -94.6% in its most recent quarter, with EPS growing -26.6% year-over-year.